SearchLIVE · CORPUS
/ Dossier
■
Sarepta Therapeutics, Inc.
HighOWNERSHIP & CONTROL
Owners / controllers
Holdings / subsidiaries
None observed in current sources.
UBO CHAIN — walk to the ultimate owner
- 1Nicaise Claudedirector→Sarepta Therapeutics, Inc.
- 1Connelly Deirdre Pdirector→Sarepta Therapeutics, Inc.
- 1Boor Kathryn Jeandirector→Sarepta Therapeutics, Inc.
- 1Chambers Michael Andrewdirector→Sarepta Therapeutics, Inc.
- 1Rothfuss Cristinofficer→Sarepta Therapeutics, Inc.
- 1Mayo Stephendirector→Sarepta Therapeutics, Inc.
- 1Arif Bilalofficer→Sarepta Therapeutics, Inc.
- 1Rodino-Klapac Louiseofficer→Sarepta Therapeutics, Inc.
- 1Wigzell Hans Lennart Rudolfdirector→Sarepta Therapeutics, Inc.
- 1Nicaise Claudedirector→Sarepta Therapeutics, Inc.
- 1Estepan Ian Michaelofficer→Sarepta Therapeutics, Inc.
- 1Murray Dallanofficer→Sarepta Therapeutics, Inc.
- 1Barry Richarddirector→Sarepta Therapeutics, Inc.
- 1BEHRENS M KATHLEENdirector→Sarepta Therapeutics, Inc.
- 1Rothfuss Cristinofficer→Sarepta Therapeutics, Inc.
- 1Arif Bilalofficer→Sarepta Therapeutics, Inc.
- 1Murray Dallanofficer→Sarepta Therapeutics, Inc.
- 1Estepan Ian Michaelofficer→Sarepta Therapeutics, Inc.
- 1Rodino-Klapac Louiseofficer→Sarepta Therapeutics, Inc.
- 1Estepan Ian Michaelofficer→Sarepta Therapeutics, Inc.
- 1Rodino-Klapac Louiseofficer→Sarepta Therapeutics, Inc.
- 1Rothfuss Cristinofficer→Sarepta Therapeutics, Inc.
- 1Murray Dallanofficer→Sarepta Therapeutics, Inc.
- 1Arif Bilalofficer→Sarepta Therapeutics, Inc.
- 1Murray Dallanofficer→Sarepta Therapeutics, Inc.
- 1Arif Bilalofficer→Sarepta Therapeutics, Inc.
- 1Estepan Ian Michaelofficer→Sarepta Therapeutics, Inc.
- 1Rodino-Klapac Louiseofficer→Sarepta Therapeutics, Inc.
- 1Rothfuss Cristinofficer→Sarepta Therapeutics, Inc.
- 1Estepan Ian Michaelofficer→Sarepta Therapeutics, Inc.
- 1Rodino-Klapac Louiseofficer→Sarepta Therapeutics, Inc.
- 1Murray Dallanofficer→Sarepta Therapeutics, Inc.
- 1Arif Bilalofficer→Sarepta Therapeutics, Inc.
- 1Estepan Ian Michaelofficer→Sarepta Therapeutics, Inc.